ResearcherGeisinger Medical CenterActive in the last 2 years
Neda Amini
Matched on ORCID iD 0000-0001-5084-1279; OpenAlex author ID A5071608760. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 5
- Trend of Adjuvant Radiation in Resected Pancreatic Ductal Adenocarcinoma: Evaluation of RTOG 0848 with a Large National Database. Last author DOI 10.1007/s12029-026-01492-0↗
- Intraductal papillary mucinous neoplasm-derived pancreatic cancer of the ventral duct in patient with pancreas divisum: a case report. First author DOI 10.1093/jscr/rjag543↗
- Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer. Co-author DOI 10.1002/jso.28003↗
- Comparison of neoadjuvant chemotherapy plus radiation vs. chemotherapy alone on complete pathologic response in pancreatic adenocarcinoma: an analysis of the n… Co-author DOI 10.1007/s44337-024-00145-0↗
- Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcop… Co-author DOI 10.1007/s11605-015-2835-y↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthew John Weiss · 3 shared papers, 2015–2025 · strength 0.51
- Paper Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer. DOI 10.1002/jso.28003↗
- Paper Comparison of neoadjuvant chemotherapy plus radiation vs. chemotherapy alone on complete pathologic response in pancrea… DOI 10.1007/s44337-024-00145-0↗
- Paper Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Ade… DOI 10.1007/s11605-015-2835-y↗
- Neha L. Lad · 2 shared papers, 2024–2025 · strength 0.46
- Danielle K. DePeralta · 2 shared papers, 2024–2025 · strength 0.46
- Gary Deutsch · 2 shared papers, 2024–2025 · strength 0.46
- Oliver J. Standring · 2 shared papers, 2024–2025 · strength 0.46
- Sagar D. Patel · 1 shared paper, 2026 · strength 0.43
- Arun A. Mavanur · 1 shared paper, 2026 · strength 0.43
- Erin M. Dickey · 1 shared paper, 2026 · strength 0.39
- Joseph Blansfield · 1 shared paper, 2026 · strength 0.39
- Shruti Koti · 1 shared paper, 2025 · strength 0.26
- Lyudmyla Demyan · 1 shared paper, 2024 · strength 0.21
- Joseph M. Herman · 1 shared paper, 2024 · strength 0.21
- Neda Rezaee · 1 shared paper, 2015 · strength 0.05
- Gaya Spolverato · 1 shared paper, 2015 · strength 0.05
- Rohan Gupta · 1 shared paper, 2015 · strength 0.05
- Ihab R. Kamel · 1 shared paper, 2015 · strength 0.05
- Georgios Antonios Margonis · 1 shared paper, 2015 · strength 0.05
- Christopher Lee Wolfgang · 1 shared paper, 2015 · strength 0.05
- Timothy Michael Pawlik · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.